AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $50.38M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| SIO | Ann: Ceasing to be a substantial holder from HML | 13/04/18 | 5 | 1.2K | |||
|
|||||||
| SIO | Ann: Change in substantial holding | 12/04/18 | 0 | 114 | |||
|
|||||||
| SIO | Ann: Change in substantial holding | 16/03/18 | 10 | 3.8K | |||
|
|||||||
| SIO | Ann: SIO Appendix 4D and 1H2018 Financial report | 02/03/18 | 3 | 756 | |||
|
|||||||
See All Discussions
ASX News